INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

Go back to INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
(NASDAQ: INMB) Delayed: 1.84 --0 (-0%)
Previous Close $1.84    52 Week High
Open $1.84    52 Week Low
Day High $1.84    P/E N/A 
Day Low $1.84    EPS
Volume 809       

(NASDAQ: INMB) Delayed: 1.84 --0 (-0%)
Previous Close $1.84    52 Week High
Open $1.84    52 Week Low
Day High $1.84    P/E N/A 
Day Low $1.84    EPS
Volume 809